Caas Capital Management LP Edwards Lifesciences Corp Call Options Transaction History

Caas Capital Management LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 28, 2024	BUY	$59.7 - $93.78 $776,100 - $1.22 Million	13,000 New	13,000 $857,000
Q1 2024 Apr 26, 2024	BUY	$72.54 - $95.56 $565,812 - $745,368	7,800 Added 123.81%	14,100 $1.35 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $456,654 - $575,424	-7,400 Reduced 54.01%	6,300 $480,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $949,136 - $1.28 Million	13,700 New	13,700 $949,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $141,094 - $160,569	1,900 Added 237.5%	2,700 $223,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $54,640 - $69,952	800 New	800 $59,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.